TrialThe Lancet. Respiratory medicine2022

An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial.

Keir E J Philip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.